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Abstract
We propose a new non-linear poroelastic model that is suited to the analysis of soft tissues. In this
paper the model is tailored to the analysis of cartilage and the engineering design of cartilage
constructs. The proposed continuum formulation of the governing equations enables the strain of
the individual material components within the extracellular matrix (ECM) to be followed over
time, as the individual material components are synthesized, assembled and incorporated within
the ECM or lost through passive transport or degradation. The material component analysis
developed here naturally captures the effect of time-dependent changes of ECM composition on
the deformation and internal stress states of the ECM. For example, it is shown that increased
synthesis of aggrecan by chondrocytes embedded within a decellularized cartilage matrix initially
devoid of aggrecan results in osmotic expansion of the newly synthesized proteoglycan matrix and
tension within the structural collagen network. Specifically, we predict that the collagen network
experiences a tensile strain, with a maximum of ~2% at the fixed base of the cartilage. The
analysis of an example problem demonstrates the temporal and spatial evolution of the stresses
and strains in each component of a self-equilibrating composite tissue construct, and the role
played by the flux of water through the tissue.
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1. Introduction
The functional role of articular cartilage is to facilitate smooth low-friction articulation and
load transmission in diarthrodial joints. Articular cartilage is a multicomponent tissue
(Heinegård, 2009) with spatially varying properties (Schinagl et al., 1997). Early attempts at
biomechanical descriptions of cartilage relied on modelling the tissue as a viscoelastic
material (e.g. Coletti et al., 1972; Hayes and Mockros, 1971). However, simple viscoelastic
models could not fully represent the complex behaviour of the tissue (Mow et al., 1980).
Interaction between the tissue's extracellular matrix (ECM) and interstitial fluid were key to
replicating many experimental findings, and any modelling framework needs to take into
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account these interactions. Poroelastic models of varying complexity do capture such
interactions and are essential to understanding the mechanical behaviour of cartilage.
Poroelastic models have physiologically meaningful parameters, such as tissue hydraulic
permeability, porosity and matrix (visco)elasticity, that can be experimentally measured
(Biot, 1962; Mow et al., 1984). As a result, poroelastic models have become the norm for
cartilage modelling. One of the most influential early models of cartilage mechanics was
proposed by Mow et al. (1980). This `biphasic' model represented the tissue matrix as a
solid phase saturated by water – the fluid phase; the solid phase is represented as a linear
elastic material, and inhomogeneity of the solid and fluid phases can be included. More
recently this biphasic framework has been extended to include orthotropic material
properties (Korhonen et al., 2003; Soulhat et al., 1999). Wilson et al. (2004) investigated the
stress in the collagen network using a biphasic swelling model that is reinforced with
collagen fibrils, and analysed example problems using the finite element method. So-called
triphasic and multiphasic models of cartilage also include the effects of electrolyte ions, in
addition to the solid and fluid phases. These models address the dynamics of tissue swelling
pressure and swelling strain associated with osmotic and electrochemical properties of the
fluid and solutes (Eisenberg and Grodzinsky, 1987; Huyghe and Janssen, 1997; Lai et al.,
1991; Lu et al., 2004). However, these previous models do not take into account the
`turnover' of ECM molecules.
Articular cartilage is a dynamic tissue, with synthesis, degradation and transport of various
ECM components all occurring simultaneously (Hascall et al., 1990). Chondrocytes produce
hundreds of extracellular and intracellular macromolecules (Heinegård, 2009), the two main
load-bearing constituents being type II collagen and the proteoglycan aggrecan. Type II
collagen fibrils are actually a heteropolymeric complex of types II, IX and XI molecules that
polymerize into fibrils (Eyre et al., 2006). Aggrecan is composed of a ~300 kDa core protein
to which are connected ~100 chondroitin sulphate (CS) and, in some species, keratin
sulphate (KS) glycosaminoglycan (GAG) chains (Ng et al., 2003). Aggrecan associates non-
covalently with hyaluronic acid (HA, hyaluronan) and the ~45 kDa link glycoprotein to
form high molecular weight aggregates (> 200 MDa), which form a densely packed,
hydrated gel enmeshed within the network of reinforcing collagen fibrils. Electrostatic
repulsion and osmotic interaction forces associated primarily with the highly negatively
charged CS GAGs develop a high swelling pressure resisted by the collagen network, and
provide > 50% of the equilibrium compressive modulus of cartilage (Buschmann and
Grodzinsky, 1995; Maroudas, 1979). Aggrecans are continuously synthesized by
chondrocytes and degraded by proteases (aggrecanases; Nagase and Kashiwagi, 2003),
whose activity is also mediated by the chondrocytes and other cells in diseased joints.
Aggrecan and other ECM degradation products are continuously lost from the tissue into the
synovial space. The spatially dependent mechanical properties of the tissue result from the
non-uniform concentrations of aggrecans, collagen fibres and other matrix molecules.
In this paper we attempt to capture the dynamic mechanical equilibrium in articular
cartilage, using an extensible modelling framework that separately accounts for each of the
primary biomechanically functional matrix constituents of cartilage. Our goals are two-fold:
(a) to develop a mathematical framework for biomechanical and biochemical modelling of
cartilage (and constructs) turnover that can be adapted to various analysis needs; and (b) to
illustrate the utility of this general mathematical framework by a simplified computational
model of osmotic swelling.
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2. Methods
2.1. General approach
Previously, DiMicco and Sah (2003) developed a continuum model to describe the
relationship between spatially varying matrix concentrations and the processes of matrix
formation, binding, degradation and molecular transport within and from the cartilage tissue.
We extend this approach by incorporating such transport issues into a fully developed
poromechanics treatment of the tissue. We also include the transport of many different types
of solutes, including growth factors, nutrients and inflammatory molecules as required. By
taking this approach, we foresee that we will be able to gain new insights into the `internal
workings' of cartilage and so have a tool to answer new questions about the tissue; e.g. what
is the predicted spatial distribution of cartilage components within the tissue, what is the
distribution of half-lives of cartilage components in the tissue, and how long would it take
for cartilage tissue constructs to achieve designed specified material properties? By
modelling the components of cartilage, we have a means for understanding the development
of the tissue and the sensitivity of the tissue to variations of each tissue component. This
should enable us to better understand the tissue and the couplings that enable homeostasis,
or facilitate tissue degradation or tissue regeneration.
We adopt a general continuum multicomponent model of cartilage, one that may be made as
simple or as complex as experimental knowledge or a particular application requires. For
example, the action of regulatory factors that control the synthesis and turnover of aggrecan,
such as the IGF-1, TGFβ, IL-1β and TNFα systems can be incorporated to model ECM
synthesis and degradation in a spatially dependent manner (Saha and Kohles, 2012; Zhang et
al., 2007). The distribution of ECM components will alter the transport and mechanical
properties, which in turn alter the component distribution. Moreover, the distribution of
these regulatory factors will be influenced by advection and diffusion, which are in turn
dependent on the material properties of the cartilage. Strain- and strain rate-dependent
physiological changes can also be introduced if required.
We illustrate the application of the proposed model, using the example of a devitalized
tissue filling with aggrecan produced by chondrocytes seeded into the construct. We
simplify our general model to a 'minimalist' model involving just three individual phases.
Even this minimalist model of cartilage is relatively complex, requiring three partial
differential equations and 15 material parameters. The model is run until final tissue
equilibrium is reached between the collagen network, the water and the production and loss
of aggrecan. Predictions of the depth-dependent aggrecan concentration and compressive
modulus made by the calibrated model are compared with the experimental work of Klein et
al. (2007). At steady state the model demonstrates its capability by being able to reproduce
the experimentally observed properties for newborn calf cartilage. That is, it can reproduce
the aggrecan distribution in newborn calf cartilage, measured cartilage compressive
stiffness. The model is also able to predict the variable strain distribution throughout the
collagen, and provide valuable insights into the dominant tissue processes that operate on
different time scales.
2.2. Cartilage tissue and construct model: cells and ECM
Cartilage ECM or tissue constructs may be generally approximated as having three principal
biomechanically functional components: (a) a structural network (for native cartilage the
structural network is the collagen network, while in a tissue construct, prior to assembly of
mature ECM, the initial structural network may be a `hydrogel', such as alginate, agarose or
any number of scaffold materials); (b) aggrecans, made of GAG chains covalently attached
to a core protein backbone (see Introduction); and (c) interstitial fluid (which is primarily
Smith et al. Page 3
J Tissue Eng Regen Med. Author manuscript; available in PMC 2014 December 20.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
water with dissolved solutes). It is generally recognized that the various components of the
ECM `turnover' on a variety of different time scales, ranging from minutes to decades. Once
the tissue components of interest and the time scale for observation of the tissue system are
known, it then becomes clearer which components of the ECM can be conveniently treated
as `fixed' in time and which components should be treated as variable in time, and which
components may be treated as solid-like vs fluid-like. In this way, a `general model' may be
adjusted and particularized on the basis of problem requirements.
To capture the general behaviours of the ECM of interest in a `minimalist model', we may
therefore start with five basic equations describing the movement, production and removal
of cells, aggrecans (and related molecules), collagens (and related molecules), signalling
molecules (e.g. growth factors, cytokines and chemokines) and of course the interstitial fluid
(the principal component of cartilage by weight). Each component of this minimalist model
is now considered in turn.
2.2.1. Structural network: collagens in the ECM—Here we consider the structural
collagen network in native cartilage tissue, but the structural network in a decellularized
tissue construct may be modelled in much the same way. However, there may be special
features of the tissue construct which will require further components, as the scaffold likely
degrades over time to be replaced by a new network of collagen. Thus, there may be a need
to consider representing two structural networks within the early evolution of a tissue
construct. Again, such a modelling choice depends on the time scale of observation; in our
example problem below, we assume that the original collagen network remains intact.
The ECM of mature articular cartilage is about 60% collagen by dry weight (Maroudas,
1979). The collagen superfamily includes 28 collagen types expressed by > 43 distinct genes
(Gordon and Hahn, 2010). The structural collagen network of the ECM is composed
primarily of heteropolymeric fibrils containing types II, IX and XI, although additional
collagens found in cartilage include types III, VI, X, XII, XIII and XIV (Eyre et al., 2006).
While fetal/newborn cartilage contains approximately 75% type II, 10% type IX and 10%
type XI, adult cartilage contains up to 90% type II, 1% type IX, 3% type XI and up to 10%
type III collagen (% of total collagen) (Eyre et al., 2006). Collagen turnover in human
articular cartilage is exceptionally slow, with a half-life estimated to be over 100 years
(Verzijl et al., 2000). Depending on need, all the equations for turnover of all relevant
collagen types may be included; however, for our minimalist model developed here, the
collagen network may be represented by three equations: (a) one for newly synthesized
collagen molecules; (b) one for the structural collagen network (type II/IX/XI fibrils); and
(c) one for degraded collagen. That is:
(1)
where the subscript col,i indicates the ith collagen constituent, with i = 1 for the newly
synthesized collagen, i = 2 for the structural network and i = 3 for the degraded collagen. In
equation (1) we might expect that the structural network form of collagen is unable to
diffuse (i.e. Dcol,2 = 0). We might also expect that the advective velocity of the newly
synthesized and degraded collagen will be a sum of the structural network collagen velocity
vcol,2 and a contribution from the interstitial fluid velocity vf. The collagen source/sink term
Rcol,i can be resolved into expressions for production and loss. This simplest case is:
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(2)
where kcol,1 is the production rate of ccol,1 per cell (units of `per time per cell'), kcol,3 is the
degradation rate of ccol,3 (units of `per time') and kcol,12 and kcol,23 describe the rate of
transition between the three forms of collagen (units of `per time'). In normal healthy
cartilage, we might expect that the primary loss of proteolytically degraded collagen from
cartilage is diffusion out through the cartilage/synovial surface, and so kcol,3 could be
negligible. As chondrocytes can alter their collagen production rate kcol,1 or produce various
enzymes to modify the rates of transition between these various states, in general these
model rate parameters are not constant, but are likely to vary over time in a coordinated
manner, according to regulatory systems controlling tissue homeostasis. Indeed, later we
will give an example in which we assume that a proportional control system is operating to
maintain collagen concentration at a set point.
Again, for simplicity, a generalized momentum balance equation for collagen is represented
here:
(3)
where j refers to all N primary components of the cartilage (i.e. cells, fluid, collagen types,
aggrecan types). The osmotically-induced volume straining of the collagen network, as
aggrecan concentration changes following aggrecan synthesis, may be introduced through
the momentum flux exchange between the aggrecan and the collagen.
A suitable non-linear elastic model for the collagen network deformation may be chosen
(e.g. one that is much stiffer in tension than compression), and again the elasticity tensor
may be time dependent, as the size and complexity of the collagen network responds to
deposition of newly synthesized collagens or degradative proteases. A suitable simple
stress–strain constitutive relationship is:
(4)
where  is the small strain tensor for the collagen network and is a non-linear, time-
dependent 6 × 6 elasticity matrix, comprising values of Young's moduli and Poisson's ratio
for the structural collagen network. For the simplest isotropic structural network, this 6 × 6
matrix reduces to just two material constants in each of tension and compression, Young's
modulus and Poisson's ratio.
2.2.2. GAGs and proteoglycans in the ECM—The ECM of mature articular cartilage
contains about 35% proteoglycans by dry weight (Maroudas, 1979). The proteoglycan (PG)
superfamily includes large and small extracellular macromolecules as well as specialized
pericellular and membrane-bound constituents (Heinegård, 2009). Aggrecan is the primary
structural, large aggregating PG in cartilage pericellular and extracellular matrix, having a
concentration and molecular structure that varies with human/animal age, cartilage depth,
location along a joint surface and radial distance from the cell. Members of the small
leucine-rich PG subfamily (SLRPs), e.g. biglycan, decorin and fibromodulin, can bind to
collagen fibrils and thereby regulate collagen fibril diameter and network self-assembly. All
these members of the PG family are defined by: (a) the amino acid sequence of their core
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proteins; and (b) the glycosylation of the core protein (elongation and sulphation of GAG
chains initiated at specific amino acid residues of the core) that takes place within the cell
during PG synthesis. Chondroitin sulphate GAGs (20–40 nm) are the main biomechanically
functional GAG chains along the aggrecan core protein, although there are also keratin
sulphate chains (~ 10 nm) present in selected regions of aggrecan. Additional members of
the PG family, along with many other ECM proteins, play an important role as binding
partners between biomechanically structural matrix elements to assemble and maintain the
integrity of the ECM. Indeed, together with tissue responses to mechanical loading, such
biochemical interactions are the foundation for the feedback processes that maintain tissue
homeostasis. Because the feedback processes within a tissue span many functional levels
and are often redundant, interactions are often observed to occur between seemingly
disparate tissue components, which may be crucial to developing a realistic representation of
tissue behaviour.
For our minimalist model of aggrecan turnover, we proceed as we did for the collagen
model. Three different equations are required, including mobile newly synthesized
aggrecans, less mobile aggrecans that are bound to hyaluronan (a binding motif stabilized by
the ~45 kDa `link' protein), and mobile degraded aggrecan fragments, generated primarily
by the aggrecanases. For simplicity, we write a general aggrecan equation that would be part
of a model of aggrecan turnover:
(5)
In equation (5), i = 1 corresponds to newly synthesized aggrecan, i = 2 for the much less
mobile aggrecan aggregate (that may be physically enmeshed within the collagen network
and/or connected to it via ECM linker molecules) and i = 3 is degraded aggrecan. While
aggrecan fragments are smaller than newly synthesized 'full-length' aggrecan, their diffusion
coefficients would likely be orders of magnitude higher than aggregated aggrecan (DiMicco
and Sah, 2003; Hascall et al., 1990). Aggrecan species may advect with the structural
collagen network, and may advect independent from the collagen network under certain
conditions. As for the collagen, we might expect the following as a simple model for the
production of aggrecan and its transition through the various forms of aggrecan considered
here:
(6)
where kagg,1 is the production rate of cagg,1 per cell (units of `per time per cell'), kagg,3 is the
degradation rate of cagg,3 (units of `per time') and kagg,12 and kagg,23 describe the rate of
transition between the three forms of aggrecan (units of `per time'). As with the production
and degradation model for collagen [equation (2)], the various rate parameters in equation
(6) are generally not constant. Instead they are expected to vary as the chondrocytes respond
to their local microenvironment (mechanical and chemical stimuli) by changing production
and degradation rates of the various aggrecans. When the degradation rate of aggrecan is
small, e.g. in young, normal healthy cartilage compared to adult osteoarthritis (OA)
cartilage, and loss from the tissue of newly synthesized (full-length) aggrecan by diffusion
may be more relevant, one may choose to neglect kagg,3.
The momentum balance for aggrecan may be written as:
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(7)
where j refers to all N primary components of the cartilage (i.e. cells, fluid, collagen types,
aggrecan types). A suitable non-linear elastic model for aggrecan deformation may be
chosen, which again may be time dependent as the cell responds to local
microenvironmental stimuli, such as strain, growth factors and cytokines, and so produces
new aggrecan molecules (and proteins that provide the structural support for the aggrecan
molecules).
Load deformation may be introduced through a simple stress–strain constitutive relationship,
viz:
(8)
where  is the small strain tensor and  is a non-linear, time-dependent elasticity
matrix, comprising values derived from osmotic moduli (viz. , see Section
2.2.7.) and Poisson's ratio. Again, for isotropic materials experiencing small changes, this 6
× 6 matrix reduces to just two material constants, Young's modulus and Poisson's ratio.
2.2.3. Chondrocytes—Chondrocytes occupy about 2–10% of the volume of articular
cartilage, depending on the age of the tissue (Gilmore and Palfrey, 1988). While
chondrocytes in normal, healthy cartilage appear to demonstrate little or no proliferation,
cartilage injury and osteoarthritis (Dreier, 2010) can induce cell proliferation in affected
regions. The time scale of observation of such events is critical to definitive conclusions
regarding proliferation. In a tissue construct, chondrocytes can undergo random movement
(migration), which can be modelled as a diffusion process. In both native cartilage and the
tissue construct there may be directed cell movement, which may be modelled as an
advection movement. That is:
(9)
The `advection' velocity of chondrocytes, vcell, can be thought of as the sum of the
chondrocyte directed migration velocity (e.g. chemoattractant-induced migration) together
with movement of the collagen structural network (within which the chondrocytes are
located), vcol,2. It is known, for example, that cell production of aggrecan can lead to local
deformation of the collagen network in native tissue and engineered constructs. Indeed, the
aggrecans serve to `inflate' the structural network, and so result in a self-equilibrating stress
state, with the structural network in tension and the aggrecan molecules in compression. The
simplest model for chondrocyte production/loss is:
(10)
where kcell is the rate of production of new chondrocytes (units of `per time per cell') and
acell is the rate of chondrocyte apoptosis/necrosis (units of `per time per cell'). These rates
will vary in time in response to the microenvironment of chondrocytes. For example,
chondrocytes near a focal defect or in a region of altered ECM caused by early OA may
undergo migration and proliferative activities in an attempt to repair local ECM (Dreier,
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2010; Hunziker and Rosenberg, 1996). The rate of chondrocyte apoptosis is likely to
change, too, depending on environmental conditions (e.g. when large mechanical strains are
encountered, particularly in the superficial zone of native cartilage, and in cell-seeded
hydrogel subject to joint articulation; Grogan et al., 2012; Kisiday et al., 2004).
We note that chondrocyte migration through the ECM is likely to be very slow under normal
physiological conditions, making their migration difficult to observe in most experimental
systems of native cartilage. For this reason, it is only recently that researchers have
suggested that chondrocytes may migrate through cartilage tissue under normal
physiological conditions (e.g. Simkin, 2008). However, it is observed that chondrocytes
migrate in vitro (Morales, 2007) and migrate in vivo sufficiently quickly to be observed on a
time scale of weeks when the amount of ECM matrix is low, as may occur in injury, repair
or disease states such as OA. Additionally, within hydrogel constructs, migration of
chondrocytes (and stem cells undergoing chondrogenesis) has been well documented, and
depends to a great extent on the mechanical and chemical properties of the scaffold (Ng et
al., 2012).
We may also write a momentum balance equation for the chondrocytes, but whether or not
this is required depends on the length scale of the chondrocyte relative to the characteristic
length scale for the problem of interest. For example, as a chondrocyte is 10–15 μm in
diameter, it may useful to include a momentum balance equation for the chondrocytes for
problem length scales up to about 100–150 μm. For length scales above several hundred
mm, the chondrocyte properties may be reasonably included within ECM properties, and for
this reason explicit momentum equations for the chondrocytes may not be required.
In any case, based on the previous momentum balance equation, the momentum balance for
chondrocytes may be written as:
(11)
where i refers to all N primary components of the cartilage (i.e. fluid, collagen types,
aggrecan types) not including cells. A suitable non-linear elastic model for cell deformation
may be chosen, which may include time-dependent parameters to reflect the cellular
responses (e.g. reorganization of cell cytoskeleton) to local microenvironmental stimuli
(such as strain, growth factors and cytokines). However, there may be osmotically-induced
volume strains in the cell due to changing intracellular proteoglycan concentrations and ion
pump responses. This osmotically induced cell deformation may be included in the model in
a way that is analogous to a temperature change in thermoelasticity. In other words, the
osmotically induced cell deformation may be introduced through a non-linear stress–strain
constitutive relationship, viz:
(12)
where  is the small strain tensor and  is a 6 × 6 elasticity matrix, comprising values
of Young's modulus and Poisson's ratio for the chondrocyte, is the coefficient of osmotic
expansion and is the osmotic pressure change relative to a reference osmotic pressure for the
cell. The elasticity tensor may be directional, non-linear and different in compression and
tension, and these cell properties may change as cells respond to changes in the local
microenvironment. In the simplest model of an isotropic cell, this 6 × 6 matrix reduces to
just two material constants, Young's modulus and Poisson's ratio.
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2.2.4. Transport of solute in the ECM—Solute molecules of possible interest here
include oxygen, nutrients, waste products from chondrocytes, growth factors such as IGF-1,
cytokines such as IL-1 and potential therapeutic molecules (small-chemical and large-
biologics) to address clinical issues of cartilage repair and OA. The movement of the ith
solute within the ECM can be with the fluid or with one of the other ECM components.
Movement with the ith solute is represented by:
(13)
where vd = vf − vagg is the Darcy flow of water (note that this representation of the Darcy
velocity presupposes that the principal drag on water arises from the GAG molecules – see
later discussion on component interactions and that solutes are primarily transported with
the fluid). Movement of solute with another phase would be described by:
(14)
where it has been assumed that diffusion in these other ECM components is negligible. The
advective velocity v is the velocity of the relevant ECM component within which the solute
is being transported. Exactly which molecules are included in an analysis depends on the
problem and the application. There is no separate momentum balance equation written for
molecular transport.
2.2.5. Transport of water in the ECM—The ECM in mature cartilage is approximately
75% water by weight (Comper, 1991). Because the pressures experienced in tissues under
physiological conditions are relatively low, water and other components may be treated as
incompressible. If it is assumed that any component is not influenced by others in the
mixture (but noting this assumption may be relaxed as required), then using the incremental
volume constraint equations leads to:
(15)
where the elastic volumetric strain of the collagen network is ev, vd is the Darcy velocity of
water,  are the net volume fluxes into the REV and  is the volume source of sink, for
components other than water and structural collagen. The above equation is of critical
importance to porous media mechanics, as it couples the solid phase deformation to fluid
phase movement, and is responsible for characteristic poroelastic behaviours such as the
Mandel–Cryer effect (Cryer, 1963).
The movement of water is induced by a gradient in the chemical potential, μw, of the water:
(16)
where μw is equal to the `hydrostatic total stress' carried by all the aggrecans
 minus the `osmotic pressure' (Π) generated
by the total aggrecan concentration; see Comper (1991) for definition of the osmotic
pressure, which is identical to the chemical potential of the aggrecan. At equilibrium the
chemical potential of the water is zero, and this occurs when .
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implicit assumption here is that the osmotic pressure generated by all other components in
the material is relatively small compared to that of the aggrecan (which is taken to include
the counter-ions required for electroneutrality of the aggrecan molecules), and that the
background electrolyte concentration is held constant.
The movement of water in porous materials is most usually represented as a so-called
`Darcy flow'. Darcy's law is a minimalist form of the momentum balance equation for water.
Darcy's law states that the Darcy flow is proportional to the gradient of the chemical
potential of the water, with the proportionality constant referred to as the hydraulic
conductivity (k) for the material, viz:
(17)
Combining equations (15) and (17) leads to:
(18)
2.2.6. Momentum interactions between material components—Until now we
have not discussed the momentum interactions between the primary cartilage components,
specifically as they relate to terms appearing in equations (3, 7 and 11). We now turn our
attention to these momentum interactions. If the primary components of cartilage are taken
to be cells, structural collagen, the three types of aggrecan (newly synthesized aggrecan,
`fixed' or aggregated aggrecan and degraded aggrecan) and water, then there are six separate
components. Theoretically, each component may interact with the other and exchange
momentum, so there may be  possible combinations of momentum interaction
between the components. But let us assume that it is the gradient of the `total' aggrecan
osmotic pressure that interacts with the collagen (and from a momentum perspective, all
components are identical in contributing to the aggrecan osmotic pressure). Then the number
of potentially significant momentum interactions is reduced to four components.
Let us now assume the drag of the aggrecan and water on the cells is zero. Let us further
assume the drag force of the water on the structural collagen network is negligible compared
to the drag resistance offered by the aggrecan GAG chains. This leaves three remaining
momentum interactions unaccounted for.
Let us assume the principal drag force of the aggrecan on the structural collagen network is
the gradient of the total aggrecan osmotic pressure. Then the body force acting on the
mobile aggrecan is given by:
(19)
and, as action and reaction are equal and opposite:
(20)
Also, we have assumed previously that the principal drag force for the water is the total
aggrecan concentration, so that:
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(21)
and, again as action and reaction are equal and opposite:
(22)
This accounts for all the component momentum interactions.
2.2.7. Osmotic potential of aggrecan—The osmotic pressure of the aggrecans in the
ECM is of critical importance of the normal function and behaviour of the cartilage tissue,
so this is discussed in more detail here. The osmotic pressure is given by Bathe et al. (2005)
as:
(23)
where cagg is the concentration of aggrecan in moles, α1 = RT is the product of the universal
gas constant and absolute temperature, and α2,3 are the first and second virial coefficients.
It turns out that the virial coefficients are important and in fact play the primary role in
generating osmotic pressures at physiological levels of aggrecan concentration found in
cartilage (Bathe et al., 2005; Comper, 1991). This is due to the fact that the aggrecan GAG
chains have a high density of ionized fixed charge groups (carboxyl and sulphate) under
physiological conditions, and the counter-ions associated with these fixed charges make the
most significant contribution to the osmotic pressure of an aggrecan polymer solution. A
reference condition (e.g. the normal physiological state) for the osmotic pressure equation
needs to be specified because the virial coefficients are strong functions of: (a) the relative
proportions of component molecules; (b) the pH; (c) the ionic strength and composition of
the bathing fluid and; (d) temperature. Having defined a reference state, an incremental
change in the osmotic pressure from that reference state is given by:
(24)
However, because the volume of the tissue may also change (say due to a deformation of the
collagen network), then a change in aggrecan concentration may occur either by the addition
of new aggrecan molecules at constant volume or by a change in volume of the solution (or
tissue), and so:
(25)
where  is the reference volume strain. Taking into account volume change of the tissue
in the incremental osmotic equation leads to:
(26)
which is sometimes written as:
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(27)
where  is called the `osmotic modulus' (Horkay et al., 2008).
As noted above, a change in the virial coefficients may result from a change in the
composition of the aggrecan polymer mixture, from a change in the ionic strength of the
bathing solution, from a change in the charge density on the aggrecan molecules (e.g. from a
change in pH of the tissue) and from a change in temperature. We see that the osmotic
pressure may be viewed as a complex hypersurface in a multidimensional state space. The
response of the osmotic pressure to changes in a variety of variables can be explored
empirically, and the hypersurface approximated in variety of different ways depending on
the purpose of the empirical investigation.
For example, if the effects of a change in background ionic strength of the bathing solution
(BIS), a change in pH of the bathing solution, a change in composition of the mixture of
polymers [e.g. say due to a change in hyaluronic acid (HA) and linker protein
concentration], a change in concentration of aggrecan concentration at constant volume and
volume deformations are to be investigated empirically, then equation (27) above may be
approximated by:
(28)
or, in terms of more experimentally accessible variables:
(29)
If these variables are now changed independently of one another, then the material
parameters may be identified. For example, dividing through by the volume strain, we find:
(30)
and, assuming the volume strain is independent of the other variables, then:
(31)
As a change in stress with respect to a change in strain is referred to as a `modulus', this
explains why  is referred to as the `osmotic modulus' (Horkay et al., 2008).
Horkay et al. (2008) experimentally examined the effect of change in composition of the
polymer mixture on osmotic pressure, and found that the addition of hyaluronic acid (HA)
and linker protein to a GAG polymer solutions to form a aggrecan polymer solution results
in a substantial reduction (about 30%) of osmotic pressure at low aggrecan concentrations
(50 mg aggrecan/ml). However, it was found that this reduction in osmotic pressure
becomes smaller as aggrecan concentration increases, so that at physiological concentrations
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of aggrecan, the effect of HA on the osmotic pressure is minimal. However, Horkay et al.
(2008) also note that the osmotic modulus is considerably increased by the presence of HA
at physiological concentrations of aggrecan.
If the experimental variables are believed not to be independent of one another, or their
values are difficult to independently control experimentally, then it may be appropriate to
just measure the osmotic modulus for specific environmental conditions and not attempt to
link this measured value to underlying changes in state variables.
Another approach is to use various theories of polymer behaviour to understand the osmotic
pressure response of the polymer mixture. For example, Donnan equilibrium theory (which
predicts ion redistributions in response to the presence of immobile or `fixed' charge) may
be employed to estimate the difference in ion concentrations (DIS = PIS − BIS) between the
polymer mixture (PIS) and the ionic strength of the bathing solution (BIS) as a function of
charge density, the aim being to separate the component of osmotic pressure change due to
change in ion distributions from that component of osmotic pressure due to the
concentration of uncharged polymers caggnull. Assuming that these two effects are
independent, a change in the osmotic pressure hypersurface is represented by:
(32)
Experimental and theoretical investigations have shown that the Donnan theory consistently
overestimates the effect of ion redistributions on the osmotic pressure, as the Donnan theory
assumes that the ion distribution in the polymer solution is uniform, when in fact at the
microscale the ion distribution is non-uniform. To take into account the non-uniform
microscale ion distribution, a microstructural model of the Poisson–Boltzmann (PB)
distribution of ions within a unit cell may be employed, and this proves to be much more
effective representation of osmotic pressure induced by the changes in ion redistribution
(Buschmann and Grodzinsky, 1995).
2.3. Example: aggrecan production within a chondrocyte seeded collagen scaffold
A common process in tissue engineering is growing artificial tissue from cell-seeded
scaffolds. In order to demonstrate the functionality of this modelling framework, we treat the
case of a decellularized cartilage matrix (Ghanavi et al., 2012) to be used as a construct for
repair of cartilage defects, based on the strategy that, devoid of antigenic cell components,
the remaining ECM has relatively low immunogenicity (Kang et al., 2012). Such cartilage-
derived scaffolds, initially devoid of cells and aggrecan, have been demonstrated to contain
a fully intact collagen fibrillar network, thereby enabling the construct to have tensile
behaviour near that of native cartilage tissue (Kheir et al., 2011). Chondrocytes can be
seeded into such constructs by a variety of methods (Gong et al., 2011; Minehara et al.,
2011), with the ultimate goal of cell synthesis of aggrecan (and other non-collagenous
proteins) so as to achieve cartilage-like depth-dependent aggrecan concentrations and
associated compressive and osmotic swelling behaviour. Starting with an initially uniform
density of seeded chondrocytes, we demonstrate the model's ability to predict spatial–
temporal increases in osmotic expansion of the newly synthesized proteoglycan matrix,
resulting in a further increase in tension within the structural collagen network (as reported
by Gong et al., 2011) that can thereby restrict proteoglycan and water movement. The
analysis also demonstrates the temporal and spatial evolution of the stresses and strains in
each component of the tissue construct.
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For simplicity, i.e. consistent with a goal of using this simplified model to illustrate the
application of the general cartilage model, the model starts with an isotropic collagen
fibrillar network derived from decellularized cartilage, uniformly seeded with chondrocytes.
The cells are assumed to synthesize and secrete aggrecan uniformly throughout the collagen
network for the duration of the simulation. The simulation is run until a dynamic equilibrium
between the concentrations and stresses of the collagen, aggrecan and water is reached. This
simulation is able to demonstrate the interaction and relative movement of the collagen,
aggrecan and fluid phases as well as the spatially varying stresses and strains developed
throughout the depth of the collagen construct.
2.4. Reduced set of equations
For this minimalist model of the tissue construct, we identify three momentum balance
equations and three constitutive relationships, one of each for the collagen network (which is
assumed unchanged over the time period of the analysis), the newly synthesized aggrecan
(represented by a spatially uniform source term in the model), and water.
The momentum balance equations are:
(33)
(34)
(35)
The collagen, aggrecan, and fluid phases are denoted by superscripts, col, agg and w,
respectively. The subscript i denotes the body force with respect to the other phases. For
example, the total body force on the collagen, Fcol, is the sum of the interaction of collagen
with aggrecan, , and collagen with water, . As all of the interaction forces between
phases are equal and opposite (e.g. ), summing the three momentum equations
gives:
(36)
The constitutive equation used here for modelling the collagen network is a bilinear
modification to the simple linear elasticity equation, σcol = Ecol/∊col, to account for a
difference in stiffness of collagen under compression vs tension. A linear model is adequate
for the small deformations considered here. In this elasticity equation ∊col represents the
strain in the collagen and Ecol represents the Young's modulus of the collagen. Here Ecol is
defined to be isotropic and stepwise linear, with ∊col > 0 in tension (Ecol = 5MPa) and ∊col <
0 in compression (Ecol = 0.5MPa; values in Table 1).
The volume constraint equation for the system is derived as follows. The volume change of
a representative elementary volume (REV) is equivalent to the divergence of the volume
flux  of the aggrecan and water, plus any volume source or sink terms :
(37)
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The collagen is treated as deformable but is not transported by diffusion or convection. For
aggrecan and extracellular fluid, we propose that the volume flux is defined as:
(38)
where ni is the volume fraction of phase i, vi is the true velocity (with respect to spatial
coordinates) and vref is the velocity of the reference phase. Collagen is defined to be the
reference material, as it simplifies the definition of boundary conditions. We chose to define
the interaction of the extracellular fluid with the aggrecan phase only, as the interaction with
the collagen phase is small in comparison. We then rewrite the above equation for the fluid
phase as:
(39)
(40)
Using the constitutive relationships for water and aggrecan defined in equation (7):
(41)
The permeabilities kw and kagg are non-linear functions of aggrecan concentration (refer to
Table 1) and are a combination of the specific conductivity and viscosity of the respective
materials. Combining the above equation with the Darcy expression for aggrecan gives our
final volume constraint equation:
(42)
We note that pagg = Πagg + pw. The aggrecan volume source  is derived from  (the
mass source as described below) using the partial specific volume of GAG 0.55 ml/g
(compiled from Franzen and Heinegard, 1984; Luscombe and Phielps, 1967; Heinegard et
al., 1981). For the purposes of this example we assume that there are no significant volume
sources or sinks for water.
We are also interested in modelling the molar concentration of aggrecan, as this determines
the osmotic pressure in the tissue and the subsequent driving force for aggrecan movement.
It is common in experimental protocols to measure the concentration of aggrecan in mg/ml
instead of molar concentrations. This is because of the variability in the molecular weight of
the aggrecan molecules. In this example we will calculate the aggrecan concentration in
units of mg/ml. We again start with a balance equation:
(43)
where cagg is the concentration of aggrecan, (fM) is the flux of the aggrecan and  is the
net source term. If we assume that aggrecan is primarily advectively transported, we can
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describe the aggrecan mass flux as fM = caggvagg. Substituting this mass flux relationship
into equation (43) gives:
(44)
Note that (vagg) can be expressed in terms of the known (vcol) as (vcol), again (pagg = Πagg +
pw), and thus the mass balance for the aggrecan becomes:
(45)
The osmotic pressure within cartilage is directly dependent on the aggrecan concentration.
Using the concentration given by equation (45), we use the following relation to calculate
the osmotic pressure (Bathe et al., 2005):
(46)
where R is the universal gas constant and (T) is the temperature (K). The constants (α1–3)
are the virial coefficients.
Equations (36, 42, 45 and 46) are our reduced set of equations that will be solved in this
example problem. These equations are solved numerically using the commercial Finite
Element Method solver Comsol Multiphysics v. 4.3. In Comsol we used the modules Solid
Mechanics [equation (36)]; Darcy's Law [equation (42)]; Coefficient PDE [equations (45
and 46)] and default settings for discretization.
2.5. Problem geometry and boundary and initial conditions
We have chosen to solve the equations in a two-dimensional (2D) geometry (see Figure 1) to
enable comparison with future 2D problems, but with boundary conditions which effectively
make the the problem a one-dimensional (1D) problem, i.e. only variation with cartilage
depth. Specifically, the geometry for the 2D cartilage construct is 1 mm deep 100 mm wide
(refer to Figure 1). The base is impermeable and fixed in space, and both sides have roller
boundary conditions (frictionless, without normal displacement). Only the top surface is
permeable to water and aggrecan, and this surface has a water boundary pressure of 0 Pa.
These boundary conditions are consistent with a section of cartilage in contact with an
underlying bone (in native tissue) or an artificial support (in the case of cartilage constructs),
surrounded to the sides by a similar matrix structure and exposed at the top surface to a
solute bath or synovial joint.
Experimentally it is observed that aggrecan concentration varies with depth and is
approximately 20–50% lower at the surface than in the middle or deep zones of normal
immature cartilage (Klein et al., 2007). This lower aggrecan concentration at the surface
may be due to several factors, including differences in the biosynthetic activity of cells in
the superficial zone (compared to those in deeper zones) as well as the time needed for
newly synthesized aggrecan to bind with high affinity to hyaluronan to form aggregates (~12
h in immature cartilage; Sandy et al., 1989) and, in the absence of such binding, the
aggrecan monomer could more easily diffuse out of the tissue. Taken together, one
modelling approach is to represent such phenomena as a transport resistance boundary
condition at the surface. Here, we use a Robin boundary condition and with aggrecan flux
Smith et al. Page 16
J Tissue Eng Regen Med. Author manuscript; available in PMC 2014 December 20.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
set to f = 2 × 10−9−10−9 cagg, as this value gives the experimentally observed concentration
of aggrecan at the construct surface (Klein et al., 2007).
The initial conditions are zero strain, zero water pressure and 0 mg/ml aggrecan within the
cartilage construct. A spatially constant source term, representing the synthesis of aggrecan
by chondrocytes seeded within the collagen scaffold, is set to  mg/ml/s
(Zhang et al., 2009). This term represents the net addition of aggrecan to the cartilage by
volume. At equilibrium it is exactly balanced by the amount of aggrecan leaving the
construct through the permeable boundary. The simulation is run until equilibrium is
reached. The parameters used in this study are shown in Table 1.
3. Results
From the initial state, aggrecan production throughout the tissue causes a steady rise in
concentration. Equilibrium was reached after 48days. The steady-state distribution of
aggrecan that forms can be seen in Figure 2. The concentration of aggrecan at the permeable
boundary is less than one-third that at the base (19.3 mg/ml compared to 61.7 mg/ml) and
rises rapidly through the first 0.5 mm of the tissue measured from the top permeable surface.
Note also (shown in Figure 2 for comparison) the experimental data provided Klein et al.
(2007) for newborn calf cartilage, i.e. a concentration of ~30 mg/ml near the cartilage
surface, rising to ~60 mg/ml 1 mm below the cartilage surface. (Figure 3)
All of the plots display quantities at 6 day intervals. The osmotic pressure within the tissue is
observed to increase along with the aggrecan, as expected from equation (13). The model
predicts an almost linear increase in the osmotic pressure from the top permeable surface
moving down through the first ~0.5 mm, with the rate of increase in osmotic pressure
decreasing in the lower half of the construct.
The osmotic pressure induces a body force in the cartilage which causes an increase in
collagen stress and strain, and thus causes an expansion of the tissue (refer to Figures 4, 5).
Water is drawn into the tissue construct as it expands. The movement of water and aggrecan
relative to each other causes a pressure within the tissue at equilibrium. Based on the model
parameters, we predict that aggrecan-induced cartilage swelling in the normal cartilage
collagen network would be, at most, only a few percent (Figure 5). (Figure 6)
The ability of cartilage to resist compressive load in equilibrium is due to the swelling
pressure associated with osmotic and electrostatic interactions due to aggrecan, along with
non-electrostatic/osmotic contributions associated with other matrix constituents. This
osmotic modulus, as described in Section 2.2.7., is plotted in Figure 7.
4. Discussion
As shown in Figure 2, the aggrecan concentration in the construct increases from zero (the
initial condition in the decellularized matrix) to a profile with a high concentration in the
deep middle and deep zones and a drop in concentration as we move towards the superficial
zone with its permeable boundary. This equilibrium state of the model is consistent with the
known depth-dependent concentration of aggrecan in immature (fetal and newborn bovine
calf; Klein et al., 2007) as well as adult (Maroudas,1979) articular cartilage. Klein et al.
(2007) reported GAG concentration of ~30 mg/ml near the surface, rising to ~60 mg/ml 1
mm below the surface (newborn calf), similar to the values in Figure 2 for the parameter
values used in Table 1.
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Figure 3 shows the aggrecan-associated osmotic pressure within the tissue, calculated from
equation (13), a major determinant of the construct mechanical and physicochemical
behaviour. The collagen stress (Figure 4) is dependent on both the osmotic pressure of
Figure 3 and the excess poor water pressure; however, because the rate of expansion of the
collagen during the experiment is low, there is very little excess pore water pressure
generated. For this reason, the collagen stress closely matches the osmotic pressure
throughout the simulation, leading to the non-uniform collagen strain profile of Figure 5. It
is worth noting that many poroelastic cartilage models attempt to represent the non-linear
material behaviour of cartilage instead by using complex non-linear material models (e.g.
Huang et al., 2003; Korhonen et al., 2003; Soulhat et al., 1999; Wilson et al., 2004; Zhang et
al., 2008), whereas here complex (non-linear and spatial varying) behaviour `naturally'
arises as the collagen, aggrecan and interstitial fluid interact. Note that the predicted
collagen strain of a few percent is consistent with experimental findings in which incubation
of cartilage plugs in high salt (1 M NaCl) reduced swelling by < 2% (Eisenberg and
Grodzinsky, 1985).
An excess pore water pressure develops during the temporal evolution of this quasistatic
steady state (Figure 6), which becomes more negative with depth, suggesting a net inward
flow of water into the tissue. However, there is no net movement of water through the tissue
at equilibrium. The small negative water pressure within the tissue has its origin in the drag
of the aggrecan on the water phase as the aggrecan slowly migrates from the tissue
construct. The residual water pressure results from the continual production of aggrecan and
its transport out of the tissue. Although not shown in Figure 6, the water pressure generated
at equilibrium predicted by our model is dependent on the permeability of the water through
the aggrecan. The lower the permeability of the aggrecan to water, or the greater the amount
of aggrecan produced, the greater the steady-state negative pressure required to resist the
drag produced by the aggrecan movement.
The osmotic modulus, as described in Section 2.2.7., provides us with a prediction of
compressive stiffness due to the aggrecan. The depth-dependent plot of osmotic modulus is
shown in Figure 7. From this we can see that the osmotic modulus at equilibrium increases
from ~50 kPa 0.1 mm below the surface to ~200 kPa 1 mm below the surface. Klein et al.
(2007) measured the depth-dependent `aggregate modulus' of fetal and newborn bovine
cartilage in compression. Table 2 shows the measurements predicted by Klein et al.
compared to the values predicted by our model.
The model predicts osmotic moduli that are greater than the aggregate tissue modulus
measured in fetal calf cartilage, and are lower than those measured in the newborn cartilage.
Comparison of model predictions to experimental data (Table 2) suggest that the osmotic
modulus is the major contributor to the overall equilibrium modulus of the intact tissue.
Figure 8 compares the osmotic modulus predicted by the model with the line of best fit for
the aggregate modulus measured by Klein et al. (2007). The variation in the data measured
by Klein et al. is much greater than the difference between the model prediction and the fit.
It should also be noted that the osmotic modulus is not exactly equal to the aggregate
modulus, as there are other components in the cartilage, i.e. collagen, elastin etc., which
contribute to the aggregate modulus. However, aggrecan is the dominant contributor to the
modulus, which allows this comparison.
The main aim of the simplified model presented here is to illustrate, through a specific
problem with associated assumptions and material laws, an implementation of the general
cartilage model. With this simple model we were able to demonstrate how the synthesis of
aggrecan and its transport through the cartilage, and a resistance at the cartilage boundary
(introduced by the Robin boundary condition), leads to a concentration gradient consistent
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with experiments. However, by explicitly separating the equations describing collagen and
aggrecan, the model predicted that a depth-dependent variation in collagen strain develops
within the tissue from an initially isotropic matrix and cell seeding/synthesis. Of course, this
is still a simple model and there are a number of additional depth-dependent variables that
could be included within the model to improve the accuracy of the output or to better
capture known features of cartilage. For example, the production rate of aggrecan is known
to vary with depth (Buschmann et al., 1996; Maroudas, 1979). The orientation, and relative
proportion, of collagen is also depth-dependent (Clark, 1990) and changes during
development (Hunziker et al., 2007; van Turnhout et al., 2010). Incorporating the variation
in collagen content and orientation would require changing the isotropic material law
currently employed to an anisotropic law. Variable collagen orientation would also result in
depth-dependent changes to aggrecan permeability, affecting aggrecan concentration,
osmotic pressure and, ultimately, the compressive modulus of the tissue model. An in-depth
study of the interaction of the depth-dependent quantities would likely demonstrate how
observed aggrecan profiles, for example, could be achieve in a variety of ways. Although
this study would be very valuable, as it would help to elucidate what combination of factors
lead to cartilage homeostasis with functional mechanical properties, and so what might be
required of an engineered scaffold, it is beyond the scope of the current study.
More broadly, the proposed general continuum formulation of cartilage ECM enables the
strain of the individual material components within the ECM to be followed over time, as
the individual material components are synthesized, assembled and incorporated within the
ECM, or lost through passive transport or degradation. Therefore, it should naturally capture
the effect of time-dependent changes of ECM composition on the deformation and internal
stress states of the ECM, rather than specifying a new and continually updated constitutive
law in an evolving cartilage. Critically, by being more explicit about how the main
components of the cartilage matrix interact, specifically taking the `solid phase' in current
cartilage models and separating it into collagen and aggrecan phases, we have turned the
focus on questions like: how do these elements interact and what determines their turnover?
We believe these questions are central to understanding cartilage in health and in disease, as
well as being central to improving strategies for cartilage tissue engineering. We would
argue that there is still no unified `story' of how cartilage `works' as a prestressed
biocomposite material in the cartilage literature. The proposed model gives the theoretical
framework to begin to develop this story.
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Figure 1.
Simulation geometry
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Figure 2.
Aggrecan concentration
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Figure 3.
Osmotic pressure
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Figure 4.
Collagen stress
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Figure 5.
Collagen strain
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Figure 6.
Excess water pressure. This pressure arises from the drag force created from the exit of
aggrecan from the tissue (refer to Discussion)
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Figure 7.
Osmotic modulus
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Figure 8.
Comparison between the osmotic modulus predicted in the model and the best fit to the
aggregate modulus data of Klein et al. (2007)
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Table 1
Model parameters used in this study
Parameter Value Reference
E col 5 MPa (> 0) 0.5 MPa (< 0) Bathe et al. (2005)
α 1 1.4 × 10−4M/g Bathe et al. (2005)
α 2 4.4 × 10−6M/g2 Bathe et al. (2005)
α 3 5.7 × 10−8M2/g3 Bathe et al. (2005)
k w 1.02 × 10−12/cagg 1.559 m2/Pa/s Comper (1993) (curve fitted)
k agg 2.7 × 10−17/cagg m2/Pa/s (minimum 4 × 10−18m2/Pa/s)
4.3 × 10−5mg/ml/s Zhang et al. (2009)
Note: the permeability of aggrecan (kagg) is assumed to be of a similar form to the permeability of water. The values of the aggrecan permeability
(and the Robin boundary condition) were not available in the literature. In this simulation these values were chosen to give the appropriate
aggrecan tissue concentration, as defined by the work of Klein et al. (2007).
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Table 2
Compressive aggregate moduli as reported by Klein et al. (2007) and osmotic modulus predicted by our model
Depth from cartilage surface
(mm)
Klein: fetal calf aggregate (tissue)
modulus (kPa)
Klein: newborn calf aggregate
(tissue) modulus (kPa)
Model osmotic modulus
(kPa)
0.1 28 ± 13 141 ± 10 50.4
1.0 150 600 ± 300 205.7
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